Beijing Leadman Biochemistry Co.,Ltd. (300289.SZ)
300289.SZ Stock Price Chart
Explore Beijing Leadman Biochemistry Co.,Ltd. interactive price chart. Choose custom timeframes to analyze 300289.SZ price movements and trends.
300289.SZ Company Profile
Discover essential business fundamentals and corporate details for Beijing Leadman Biochemistry Co.,Ltd. (300289.SZ) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Devices
IPO Date
16 Feb 2012
Employees
538.00
Website
https://www.leadmanbio.comCEO
Ouyang Xu
Description
Beijing Leadman Biochemistry Co.,Ltd. engages in the research and development, manufacture, and sale of in vitro diagnostic products in the People's Republic of China. The company offers biochemical raw materials, such as enzymes, coenzymes, antibodies, buffers, enzyme substrates, culture media, stain reagents, amino acids, and other products primarily for biotechnology, clinical diagnosis, drug development, chemical production, and other related applications. It also provides biochemistry diagnostic and companion reagents. In addition, the company offers medical instruments, such as EnigmaML, an automated molecular test platform for use in clinical laboratory and at the point-of-care, including clinics, doctor's surgeries, and pharmacies; DiaSys InnovaStar, an automatic compact POCT analyzer to deliver result quality comparable to measurements on laboratory analyzers; DiaSys Respons, a random access bench top analyzer; CI1000 automatic chemiluminescence immunoassay analyzers; and IDS-isys, an instrument to enhance performance and productivity. The company was founded in 1997 and is headquartered in Beijing, the People's Republic of China.
300289.SZ Financial Timeline
Browse a chronological timeline of Beijing Leadman Biochemistry Co.,Ltd. corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 29 Apr 2025
EPS came in at -¥0.14 , while revenue for the quarter reached ¥88.41M .
Earnings released on 31 Mar 2025
EPS came in at -¥0.00 , while revenue for the quarter reached ¥78.91M .
Earnings released on 29 Sept 2024
EPS came in at ¥0.00 , while revenue for the quarter reached ¥93.47M .
Earnings released on 29 Jun 2024
EPS came in at ¥0.01 , while revenue for the quarter reached ¥91.35M .
Dividend declared on 17 May 2024
A dividend of ¥0.01 per share was announced, adjusted to ¥0.01. The dividend was paid on 17 May 2024.
Earnings released on 29 Apr 2024
EPS came in at -¥0.02 , while revenue for the quarter reached ¥118.51M .
Earnings released on 30 Mar 2024
EPS came in at -¥0.00 , while revenue for the quarter reached ¥91.80M .
Earnings released on 30 Sept 2023
EPS came in at ¥0.01 , while revenue for the quarter reached ¥113.19M .
Earnings released on 30 Jun 2023
EPS came in at ¥0.02 , while revenue for the quarter reached ¥118.80M .
Earnings released on 31 Mar 2023
EPS came in at ¥0.02 , while revenue for the quarter reached ¥108.15M .
Earnings released on 1 Jan 2023
EPS came in at -¥0.15 , while revenue for the quarter reached ¥164.02M .
Earnings released on 30 Sept 2022
EPS came in at ¥0.02 , while revenue for the quarter reached ¥167.68M .
Earnings released on 30 Jun 2022
EPS came in at ¥0.02 , while revenue for the quarter reached ¥182.70M .
Dividend declared on 19 May 2022
A dividend of ¥0.02 per share was announced, adjusted to ¥0.02. The dividend was paid on 19 May 2022.
Earnings released on 31 Mar 2022
EPS came in at ¥0.02 , while revenue for the quarter reached ¥191.58M .
Earnings released on 31 Dec 2021
EPS came in at -¥0.01 , while revenue for the quarter reached ¥149.75M .
Earnings released on 30 Sept 2021
EPS came in at ¥0.03 , while revenue for the quarter reached ¥168.79M .
Earnings released on 30 Jun 2021
EPS came in at ¥0.02 , while revenue for the quarter reached ¥129.79M .
Earnings released on 28 Apr 2021
EPS came in at -¥0.12 , while revenue for the quarter reached ¥146.72M .
Earnings released on 31 Mar 2021
EPS came in at ¥0.02 , while revenue for the quarter reached ¥115.72M .
Earnings released on 30 Sept 2020
EPS came in at ¥0.03 , while revenue for the quarter reached ¥148.65M .
300289.SZ Stock Performance
Access detailed 300289.SZ performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.